In leukaemia the gain-of-function of ASXL1 mutants increase PR-DUB activity; the stabilization of BAP1 and its undue ASXL1 mutant-dependent chromatin recruitment leads to aberrant oncogenic pattern of gene expression [42, 43]. Here, ASXL1 is linked to leukemia.